Larvol Delta - High-levels-of-pain-response-with-sonelokimab-in-VELA1-and-VELA2-two-Phase-3-trials-in-patients-with-moderatetosevere-HS

sonelokimab (M1095) - Avillion, MoonLake Immunotherap

https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/63479

Brian Kirby

Aug 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next